Enalapril vs Rituximab

Enalapril vs Rituximab: Overview

This comparison examines the pharmacological differences between Enalapril and Rituximab.

Mechanism of Action

Enalapril: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Enalapril — 11 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Enalapril — C20H28N2O5.

Molecular Weight: Enalapril — 376.4470 g/mol.

Type: Enalapril — Small molecule; Rituximab — Antibody.